Optogenetic and chemogenetic therapies for epilepsy. (2020)
Attributed to:
Gene therapy for refractory epilepsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.neuropharm.2019.107751
PubMed Identifier: 31494141
Publication URI: http://europepmc.org/abstract/MED/31494141
Type: Journal Article/Review
Volume: 168
Parent Publication: Neuropharmacology
ISSN: 0028-3908